The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
A comprehensive overview of exosomes as drug delivery vehicles — Endogenous nanocarriers for targeted cancer therapy
Abstract
Exosomes denote a class of secreted nanoparticles defined by size, surface protein and lipid composition, and the ability to carry RNA and proteins. They are important mediators of intercellular communication and regulators of the cellular niche, and their altered characteristics in many diseases, such as cancer, suggest them to be important both for diagnostic and therapeutic purposes, prompting the idea of using exosomes as drug delivery vehicles, especially for gene therapy. This review covers the current status of evidence presented in the field of exosome-based drug delivery systems. Components for successful exosome-based drug delivery, such as choice of donor cell, therapeutic cargo, use of targeting peptide, loading method and administration route are highlighted and discussed with a general focus pertaining to the results obtained in models of different cancer types. In addition, completed and on-going clinical trials are described, evaluating exosome-based therapies for the treatment of different cancer types. Due to their endogenous origin, exosome-based drug delivery systems may have advantages in the treatment of cancer, but their design needs further refinement to justify their usage on the clinical scale.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, their high biocompatibility and low immunogenicity enhance their uptake profile, their stability in systemic circulation, and their in vitro and in vivo therapeutic efficacy [229,230].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [230]
Citations
Cites
1 retracted
Rana, S., Yue, S., Stadel, D., & Zöller, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.06.018 · Cited by 688
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, É. (2009) · Nature reviews. Immunology · doi:10.1038/nri2567 · Cited by 3,996
Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajković, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,760
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Flagged first, then by citations
1 of the 125 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 703
Wen, F., Han, Y., Zhang, H., Zhao, Z., Wang, W., Chen, F., Qin, W., Ju, J., An, L., Yan, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54850-6 · Cited by 30
Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment
Massey, A. E., Malik, S., Sikander, M., Doxtater, K. D., Tripathi, M. K., Khan, S., Yallapu, M. M., Jaggi, M., Chauhan, S. C., & Hafeez, B. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105278 · Cited by 27
Chen, Z., Yuan, R., Hu, S., Yuan, W., & Sun, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817942 · Cited by 28
Extracellular Vesicles: A Novel Tool in Nanomedicine and Cancer Treatment
Stavrou, A., & Ortiz, A. (2022) · Cancers · doi:10.3390/cancers14184450 · Cited by 27
Fluorescence Spectroscopic Analysis of Lateral and Transbilayer Fluidity of Exosome Membranes
Yasuda, T., Watanabe, H., Hirosawa, K. M., Suzuki, K. G. N., Suga, K., & Hanashima, S. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c02258 · Cited by 27
Unlocking Exosome-Based Theragnostic Signatures: Deciphering Secrets of Ovarian Cancer Metastasis
Mukherjee, S., Nag, S., Mukerjee, N., Maitra, S., Muthusamy, R., Fuloria, N. K., Fuloria, S., Adhikari, M. D., Anand, K., Thorat, N. D., et al. (2023) · ACS Omega · doi:10.1021/acsomega.3c02837 · Cited by 27
Ashrafizadeh, M., Luo, K., Zhang, W., Aref, A. R., & Zhang, X. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117443 · Cited by 29
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds
Biasutto, L., Mattarei, A., Spina, M. L., Azzolini, M., Parrasia, S., Szabó, I., & Zoratti, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.060 · Cited by 28
Li, M., Yang, P., Wu, J., Ni, R., Yuan, H., Guo, Z., Zou, J., Gao, W., Cong, H., & Jin, Q. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.110875 · Cited by 26
George, J., Yan, I. K., & Patel, T. C. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0053-4 · Cited by 26
Reprogramming Exosomes for Immunotherapy
Cheng, Q., Shi, X., & Zhang, Y. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0203-4_12 · Cited by 27
Si, Y., Guan, J.-S., Xu, Y., Chen, K., Kim, S., Zhou, L., Jaskula‐Sztul, R., & Liu, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111079 · Cited by 26
Jackson, K. K., Powell, R. R., Bruce, T. F., & Marcus, R. K. (2021) · The Analyst · doi:10.1039/d1an00373a · Cited by 27
Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies
Allegra, A., Petrarca, C., Gioacchino, M. D., Casciaro, M., Musolino, C., & Gangemi, S. (2022) · Cells · doi:10.3390/cells11071128 · Cited by 26
Current Update on the Role of Enhanced Permeability and Retention Effect in Cancer Nanomedicine
Jasim, A. A., Abdelghany, S., & Greish, K. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809717-5.00002-6 · Cited by 26
Choi, J. U., Park, I., Lee, Y.-K., & Hwang, S. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197363 · Cited by 27
Forró, T., Manu, D. R., Băjenaru, O., & Bălașa, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115726 · Cited by 25
Angeloni, N. L., McMahon, K. M., Swaminathan, S., Plebanek, M. P., Osman, I., Volpert, O. V., & Thaxton, C. S. (2016) · Scientific Reports · doi:10.1038/srep22915 · Cited by 25
Bark, J. M., Kulasinghe, A., Amenábar, J. M., & Punyadeera, C. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.06.006 · Cited by 25
Huang, T., & He, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7253-1_15 · Cited by 25
Babajani, A., Moeinabadi‐Bidgoli, K., Niknejad, F., Rismanchi, H., Shafiee, S., Shariatzadeh, S., Jamshidi, E., Farjoo, M. H., & Niknejad, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02794-3 · Cited by 24
Allegretta, C., D’Amico, E., Manuti, V., Avolio, C., & Conese, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073829 · Cited by 27
Decoding the role of extracellular vesicles in liver diseases
Deng, F., Magee, N. S., & Zhang, Y. (2017) · Liver Research · doi:10.1016/j.livres.2017.11.003 · Cited by 24
The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
Weston, W. W., Ganey, T. M., & Temple, H. T. (2019) · BioDrugs · doi:10.1007/s40259-019-00338-5 · Cited by 24
Seyfizadeh, N., Seyfizadeh, N., Borzoueisileh, S., Elahimanesh, F., Hosseini, V., & Nouri, M. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.06.025 · Cited by 24
In vivo CT imaging of gold nanoparticle-labeled exosomes in a myocardial infarction mouse model
Gong, L.-G., Weng, Y., Zhou, W., Zhang, K.-C., Li, W., Jiang, J., & Zhu, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-981 · Cited by 19
Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
Papadakos, S. P., Dedes, N., Pergaris, A., Gazouli, M., & Theocharis, S. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073620 · Cited by 23
Impact of exosome therapy on pancreatic cancer and its progression
El‐Tanani, M., Nsairat, H., Matalka, I. I., Aljabali, A. A. A., Mishra, V. K., Mishra, Y., Naikoo, G. A., Chava, S. R., Charbe, N. B., & Tambuwala, M. M. (2023) · Medical Oncology · doi:10.1007/s12032-023-02101-x · Cited by 24
Extracellular vesicles: powerful candidates in nano-drug delivery systems
Liu, X., Cao, Y., Wang, S., Liu, J., & Hao, H. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01411-x · Cited by 24
Davis, C. N., Winters, A. L., Milic, I., Devitt, A., Cookson, A., Brophy, P. M., & Morphew, R. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69970-4 · Cited by 23
Gangadaran, P., Li, X. J., Kalimuthu, S., Oh, J. M., Hong, C. M., Rajendran, R. L., Lee, H., Zhu, L., Baek, S. H., Jeong, S. Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31998-y · Cited by 22
Engineering of Exosomes: Steps Towards Green Production of Drug Delivery System
Sherif, A. Y., Harisa, G. I., Alanazi, F. K., & Youssof, A. M. E. (2019) · Current Drug Targets · doi:10.2174/1389450120666190715104100 · Cited by 22
Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma
Samal, S., Dash, P., & Dash, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s307843 · Cited by 22
Rezakhani, L., Alizadeh, M., Sharifi, E., Soleimannejad, M., & Alizadeh, A. (2021) · PubMed Central · doi:10.22074/cellj.2021.7595 · Cited by 22
Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers
Si, Y., Chen, K., Ngo, H. G., Guan, J. S., Totoro, A., Zhou, Z. “., Kim, S., Kim, T. H., Zhou, L., & Liu, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010146 · Cited by 22
Zhu, Q., Zhu, R., & Jin, J. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12125 · Cited by 22
Exosomes: A Paradigm in Drug Development against Cancer and Infectious Diseases
Oves, M., Qari, H. A., Felemban, N. M., Khan, A. A. P., Rehan, M., Tabrez, S. S. M., Ahmed, F., Haque, A., Khan, M. S., Khan, J. M., et al. (2018) · Journal of Nanomaterials · doi:10.1155/2018/6895464 · Cited by 23
Zhang, L., Yin, W., Tong, Y., Zhang, Y., Xu, Y., Liu, S., Dai, Z., & Zou, X. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c01378 · Cited by 21
A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics
Amina, S. J., Azam, T., Dagher, F., & Guo, B. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2305115 · Cited by 21
Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
Huang, C.-L., Liu, S., Tong, X., & Fan, H. S. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3586-8 · Cited by 22
Platelet microparticles: An effective delivery system for anti-viral drugs
Soleymani, S., Yari, F., Bolhassani, A., & Bakhshandeh, H. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.03.009 · Cited by 21
Pătraș, L., & Banciu, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190701143845 · Cited by 21
Exosome-Derived Noncoding RNAs as a Promising Treatment of Bone Regeneration
Yin, B., Ma, Q., Song, C., Zhao, L., Yu, F., Wang, C., Shi, Y., & Ye, L. (2021) · Stem Cells International · doi:10.1155/2021/6696894 · Cited by 20
Electrochemical microfluidic paper-based analytical devices for tumor marker detection
Yuan, Y., Liu, B., Wang, T., Li, N., Zhang, Z., & Zhang, H. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116816 · Cited by 21
Sedykh, S. E., Purvinsh, L. V., Burkova, E. E., Dmitrenok, P. S., Ryabchikova, E. I., & Nevinsky, G. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416106 · Cited by 20
Gao, T. X., Lin, Y.-Q., Ye, H., & Lin, W.-M. (2023) · Neoplasma · doi:10.4149/neo_2023_230711n362 · Cited by 20
Exosomes as new generation vehicles for drug delivery systems
Dilsiz, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105562 · Cited by 21
Vosoughi, P., Naghib, S. M., Kangarshahi, B. M., & Mozafari, M. R. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139532 · Cited by 23
Myocardial Regeneration via Progenitor Cell-Derived Exosomes
Maring, J. A., Beez, C. M., Falk, V., Seifert, M., & Stamm, C. (2017) · Stem Cells International · doi:10.1155/2017/7849851 · Cited by 21
Trends towards Biomimicry in Theranostics
Evangelopoulos, M., Parodi, A., Martinez, J. O., & Tasciotti, E. (2018) · Nanomaterials · doi:10.3390/nano8090637 · Cited by 20
Janus nanocarrier powered by bi-enzymatic cascade system for smart delivery
Jiménez‐Falcao, S., Joga, N., García‐Fernández, A., Llopis‐Lorente, A., Torres, D., de Luis, B., Sancenón, F., Martínez‐Ruiz, P., Martínez‐Máñez, R., & Villalonga, R. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00938h · Cited by 20
Clinical applications of extracellular vesicle long RNAs
Chen, S., Zhu, X., & Huang, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1751584 · Cited by 20
Zhang, Z., Shi, C., & Wang, Z. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1279469 · Cited by 21
The Role of Exosomes in Cancer Progression and Therapy
Sergazy, S., Seydahmetova, R., Gulyayev, A., Shulgau, Z., & Aljofan, M. (2025) · Biology · doi:10.3390/biology14010027 · Cited by 23
Superfluorinated Extracellular Vesicles for In Vivo Imaging by 19F-MRI
Sancho‐Albero, M., Ayaz, N., Sebastián, V., Chirizzi, C., Encinas‐Giménez, M., Neri, G., Chaabane, L., Luján, L., Martín‐Duque, P., Metrangolo, P., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20566 · Cited by 20
Köksal, A. R., Ekmen, N., Aydın, Y., Núñez, K., Sandow, T. A., Delk, M., Moehlen, M., Thevenot, P., Cohen, A. J., & Dash, S. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s423043 · Cited by 20
Deng, S., Zeng, D., Luo, Y., Zhao, J., Li, X., Zhao, Z., & Chen, T. (2017) · RSC Advances · doi:10.1039/c6ra28801d · Cited by 19
Aqil, F., Munagala, R., Agrawal, A. K., & Gupta, R. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814619-4.00010-0 · Cited by 19
Exosome-Mediated Crosstalk Between Cancer Cells and Tumor Microenvironment
Saad, S. H., Kashanchi, A., Zadeh, M. A., Williams, A., & Batrakova, E. V. (2025) · Cells · doi:10.3390/cells14221750 · Cited by 25
Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells
Jahagirdar, D., Purohit, S., Jain, A. Y., & Sharma, N. K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00147 · Cited by 18
Yang, Y.-S., Jia, X.-Z., Lu, Q.-Y., Cai, S.-L., Huang, X.-T., Yang, S., Wood, C., Wang, Y., Zhou, J., Chen, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02278-x · Cited by 18
Engineered Exosomes as a Photosensitizer Delivery Platform for Cancer Photodynamic Therapy
Dao, A., Kushwaha, R., Kumar, A., Huang, H., & Banerjee, S. (2022) · ChemMedChem · doi:10.1002/cmdc.202200119 · Cited by 18
Ke, Z., Wei, X., Zhi, Z., Zhang, S., Cui, L., Li, Y., Chen, X., Yao, J., & Zhang, H. (2022) · Life · doi:10.3390/life12111942 · Cited by 18
Urinary exosomes: Diagnostic impact with a bioinformatic approach
Perpétuo, L., Ferreira, R. M., Thongboonkerd, V., Guedes, S. D. M., Amado, F. M. L., & Vitorino, R. M. P. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.07.002 · Cited by 21
Rademacher, D. J. (2023) · Biomedicines · doi:10.3390/biomedicines11041187 · Cited by 18
Li, Z., Mbah, N. E., & Maltese, W. A. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3130-x · Cited by 18
Marazioti, A., Παπαδιά, Κ., Kannavou, M., Σπέλλα, Μ., Basta, A., de Lastic, A.-L., Rodi, M., Mouzaki, Α., Samiotaki, M. K., Panayotou, G., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257097 · Cited by 19
Hao, D., Li, Y., Zhao, G.-F., & Zhang, M. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13175 · Cited by 18
Hayes, S. H., Liu, Q., Selvakumaran, S., Haney, M. J., Batrakova, E. V., Allman, B. L., Walton, P. A., Kiser, P. K., & Whitehead, S. N. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00390-6 · Cited by 18
Biological Roles and Clinical Significance of Exosome-Derived Noncoding RNAs in Bladder Cancer
Tong, Y., Liu, X., Ding, X., Peng, E., Yang, X., Liu, H., Ye, T., Wang, X., He, Y., Xu, H., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704703 · Cited by 18
Lu, Y., Cao, G., Lan, H., Liao, H., Hu, Y., Feng, H., Liu, X., & Huang, P. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101289 · Cited by 18
Bernardino, R. M. M., Leao, R. R. N., Henrique, R., Pinheiro, L. C., Kumar, P., Suravajhala, P., Beck, H. C., Carvalho, A. S., & Matthiesen, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413605 · Cited by 19
Texosome-based drug delivery system for cancer therapy: from past to present.
Hosseini, H. M., Halabian, R., Amin, M., & Fooladi, A. A. I. (2015) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2015.0045 · Cited by 18
Mu, Y., Zhang, X., Zhang, L., Luo, R., Zhang, Y., & Wang, M. (2024) · Molecules · doi:10.3390/molecules29174281 · Cited by 17
Singh, B. K., Cooney, A. L., Krishnamurthy, S., & Sinn, P. L. (2020) · Genes · doi:10.3390/genes11040351 · Cited by 17
Chao, T., Zhao, J., Gao, R., Wang, H., Guo, J., Gao, Z., & Wang, Y. (2025) · Advanced technology in neuroscience . · doi:10.4103/atn.atn-d-24-00025 · Cited by 21
Inducible RNAi system and its application in novel therapeutics
Liao, Y., & Tang, L. (2015) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2014.1003030 · Cited by 17
The Biology and Therapeutic Applications of Red Blood Cell Extracellular Vesicles
Zhang, D. X., Kiomourtzis, T., Lam, C. K., & Le, M. T. N. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81758 · Cited by 19
Gener, P., González‐Callejo, P., Seras‐Franzoso, J., Andrade, F., Rafael, D. F. D. S., Abasolo, I., & Schwartz, S. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0099 · Cited by 17
Characterization of RNA in Extracellular Vesicles
Fischer, S., & Deindl, E. (2021) · Applied Sciences · doi:10.3390/app11167520 · Cited by 18
Genetically reprogrammed exosomes for immunotherapy of acute myeloid leukemia
Zhang, L., Kao, G., Zhao, Y., Zhang, Z., Kim, H. S., Shi, X., Cheng, Q., Hou, T., Lenz, H., & Zhang, Y. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.025 · Cited by 17
Advances in Research on Exosomal miRNAs in Central Nervous System Diseases
Feng, G., Lan, X., Qin, S., Shi, Y., Zhao, Q., Li, Q., & Zhong, L. (2025) · ASN NEURO · doi:10.1080/17590914.2025.2465546 · Cited by 21
Gangadaran, P., Gunassekaran, G. R., Rajendran, R. L., Oh, J. M., Vadevoo, S. M. P., Lee, H., Hong, C. M., Lee, B.-H., Lee, J., & Ahn, B. (2022) · Biomedicines · doi:10.3390/biomedicines10081978 · Cited by 17
Asfiya, R., Xu, L., Paramanantham, A., Kabytaev, K., Chernatynskaya, A., McCully, G., Yang, H., & Srivastava, A. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01404 · Cited by 18
Relationship between exosomes and cancer: formation, diagnosis, and treatment
Huang, C., Li, J., Xie, Z., Hu, X., & Huang, Y. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.95763 · Cited by 19
‘Smartening’ anticancer therapeutic nanosystems using biomolecules
Núñez‐Lozano, R., Cano, M., Pimentel, B., & Mendez, G. A. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.07.005 · Cited by 16
Exosomes as Drug Delivery Vehicles for Cancer Treatment
Narayanan, E. (2019) · Current Nanoscience · doi:10.2174/1573413715666190219112422 · Cited by 16
The Potential Role of Exosomes in the Treatment of Brain Tumors, Recent Updates and Advances
Huang, Z., Keramat, S., Izadirad, M., Chen, Z., & Soukhtanloo, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869929 · Cited by 16
Gadok, A. K., Zhao, C., Meriwether, A. I., Ferrati, S., Rowley, T. G., Zoldan, J., Smyth, H. D. C., & Stachowiak, J. C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00688 · Cited by 16
Mesenchymal Cell-Derived Exosomes as Novel Useful Candidates for Drug Delivery
Einabadi, M., Ai, J., Kargar, M., Kafilzadeh, F., Nooshabadi, V. T., & Jamali, H. (2020) · Archives of Neuroscience · doi:10.5812/ans.98722 · Cited by 16
Swain, A., Jena, S. R., & Samanta, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1687953 · Cited by 17
Simonsen, J. B., Larsen, J. B., Hempel, C., Eng, N., Fossum, A., & Andresen, T. L. (2019) · Cytometry Part A · doi:10.1002/cyto.a.23797 · Cited by 15
Farkhad, N. K., Mahmoudi, A. A., & Mahdipour, E. (2022) · Regenerative Therapy · doi:10.1016/j.reth.2022.03.006 · Cited by 15
Vahabi, M., Comandatore, A., Centra, C., Blandino, G., Morelli, L., & Giovannetti, E. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.11.003 · Cited by 15
Exosomes: potential model for complement-stealth delivery systems
Milosevits, G., Szebeni, J., & Krol, S. (2015) · European Journal of Nanomedicine · doi:10.1515/ejnm-2015-0005 · Cited by 15
Erb, U., Zhao, K., Wang, Z., Xiao, L., & Zöller, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.005 · Cited by 15
Catching filopodia: Exosomes surf on fast highways to enter cells
Schneider, A., & Simons, M. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201604024 · Cited by 14
Sonodynamic biomimetic-nanomedicine fight cancers
Zhang, A., Zheng, X., Yan, G., Liu, X., Xie, D., Xu, X., Sun, M., & Liu, Z. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03583-9 · Cited by 16
Nanoparticle-Labeled Exosomes as Theranostic Agents: A Review
Hamzah, R. N., Alghazali, K. M., Biris, A. S., & Griffin, R. J. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c01426 · Cited by 14
Farashah, M. S. G., Javadi, M., Rad, J. S., Shakouri, S. K., Asnaashari, S., Dastmalchi, S., Nikzad, S., & Roshangar, L. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.072 · Cited by 14
Metadata
- Authors
- Johnsen, K. B., Gudbergsson, J. M., Skov, M. N., Pilgaard, L., Moos, T., & Duroux, M.
- Affiliations
- Aalborg University (DK)
- Corresponding author
- Duroux, Meg
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 1846
- Issue
- 1
- Pages
- 75-87
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2151079805
- Cited by
- 704
- References
- 125
- Citations by year
- 2026: 16 · 2025: 45 · 2024: 51 · 2023: 60 · 2022: 63 · 2021: 69 · 2020: 77 · 2019: 78 · 2018: 82 · 2017: 76 · 2016: 46 · 2015: 34 · 2014: 6
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (publishedVersion)
- PubMed (publishedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- Harboefonden (839070)
- Spar Nord Fonden (839071)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- exosomes, exosome-based drug delivery, targeted cancer therapy, gene therapy, intercellular communication, targeting peptides, route of administration, clinical trials, cancer
- MeSH terms
- Animals, Antineoplastic Agents, Drug Carriers, Humans, Neoplasms, Pharmaceutical Vehicles, Nanoparticles, Exosomes, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review